HEPGEL OINTMENT
Heparin 2500 IU
Gland Pharma Ltd
It is available as a solution for injection to be administered by a healthcare provider into the vein.
Store at a temperature not exceeding 30°C.
Hypersensitivity to heparin Haemophilia and other haemorrhagic disorders Thrombocytopenia Peptic ulcer Recent cerebral haemorrhage Severe hypertension Severe liver or renal disease After major trauma or recent surgery (especially to eye or nervous system) Threatened abortion Piles Bacterial endocarditis Large malignancies Tuberculosis Lumbar puncture Chronic alcoholics Acetylsalicylic acid and other antiplatelet drugs
Diabetes mellitus : Diabetes mellitus, or simply diabetes, is a group of metabolic diseases in which a person has high blood sugar, either because the pancreas does not produce enough insulin, or because cells do not respond to the insulin that is produced. There are roles for patient education, dietetic support, and sensible exercise, with the goal of keeping both short-term and long-term blood glucose levels within acceptable bounds. In addition, given the associated higher risks of cardiovascular disease, lifestyle modifications are recommended to control blood pressure. Medication include 1Insulin, 2Sensitizers 2.1 Biguanides 2.2 Thiazolidinediones 3Secretagogues 3.1 Sulfonylureas 3.2 Nonsulfonylureasecretagogues 4 Alpha-glucosidase inhibitors 5 Peptide analogs 5.1 Injectable Incretinmimetics 5.2 Injectable Amylin analogues
Cephalosporins which contain the MTT side chain may increase the risk of hemorrhage. Drugs which affect platelet function (eg, aspirin, NSAIDs, dipyridamole, ticlopidine, clopidogrel) may potentiate the risk of hemorrhage. Nitroglycerin (I.V.) may decrease heparin's anticoagulant effect. This interaction has not been validated in some studies, and may only occur at high nitroglycerin dosages. Penicillins (parenteral) may prolong bleeding time via inhibition of platelet aggregation, potentially increasing the risk of hemorrhage. Thrombolytic agents increase the risk of hemorrhage. Warfarin: Risk of bleeding may be increased during concurrent therapy. Heparin is commonly continued during the initiation of warfarin therapy to assure anticoagulation and to protect against possible transient hypercoagulability. Other drugs reported to increase heparin's anticoagulant effect include antihistamines, tetracycline, quinine, nicotine, and cardiac glycosides (digoxin).
Whether you're looking for a doctor for dealing with your own medical condition, click here to find right physician.
It is any effect of a drug, chemical, or other medicine that is in addition to its intended effect, especially an effect that is harmful or unpleasant.